These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6136893

  • 1. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus.
    Dimitriadis G, Tessari P, Gerich J.
    Metabolism; 1983 Oct; 32(10):987-92. PubMed ID: 6136893
    [Abstract] [Full Text] [Related]

  • 2. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD, Tessari P, Go VL, Gerich JE.
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [Abstract] [Full Text] [Related]

  • 3. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA, Bock A, Keller U.
    Diabetes Care; 1985 Mar; 8(5):429-35. PubMed ID: 2865093
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, pharmacokinetics and tolerability of a somatostatin analogue (L-363,586) in insulin-dependent diabetes mellitus.
    Gottesman I, Tobert J, Vandlen R, Gerich J.
    Life Sci; 1986 Jun 16; 38(24):2211-9. PubMed ID: 2872569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.
    Gerich JE, Lorenzi M, Karam JH, Schneider V, Forsham PH.
    JAMA; 1975 Oct 13; 234(2):159-5. PubMed ID: 1242153
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
    Gutniak M, Grill V, Wiechel KL, Efendić S.
    Diabetes; 1987 Jul 13; 36(7):802-7. PubMed ID: 2884157
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
    Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR.
    Diabetes Care; 2003 Jan 13; 26(1):1-8. PubMed ID: 12502651
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Somatostatin reduces posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
    Kollind M, Adamson U, Lins PE.
    Acta Endocrinol (Copenh); 1988 Jun 13; 118(2):173-8. PubMed ID: 2898855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.